Cargando…
P15-15. Advocates' perspectives on community engagement in the HVTN 505
Autores principales: | Warren, M, Bass, E, Feuer, C, Fisher, K, Grant, D, Miller, L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767711/ http://dx.doi.org/10.1186/1742-4690-6-S3-P216 |
Ejemplares similares
-
P15-24. Good participatory practice guidelines begin to take root
por: Miller, L, et al.
Publicado: (2009) -
P15-21. Investigating the utility and relevance of the good participatory practice guidelines for biomedical HIV prevention trials
por: Miller, L, et al.
Publicado: (2009) -
P15-08. Did unblinding affect HIV risk behaviour and risk perception in the HVTN503/Phambili study?
por: Gray, GE, et al.
Publicado: (2009) -
P15-13. HVTN 503(Phambili) trial discontinuation of enrolment/vaccination: the impact on trial participant attitudes to vaccine trials and scientific research
por: Mark, D, et al.
Publicado: (2009) -
P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
por: Fisher, K, et al.
Publicado: (2009)